Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 3 Neoplasms 3 Glioma 2 Glioblastoma 2 Breast Neoplasms 2 Xeroderma Pigmentosum 1 Uterine Cervical Dysplasia 1 Trichothiodystrophy Syndromes 1 Squamous Intraepithelial Lesions 1 Spinal Cord Neoplasms 1 Sexuality 1 Sarcoma 1 Prostatic Neoplasms 1 Pilonidal Sinus 1 Ovarian Neoplasms 1 Neurofibroma 1 Meningioma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Ependymoma 1 Endometrial Neoplasms 1 DNA Repair-Deficiency Disorders 1 Cockayne Syndrome 1 Cardiovascular Diseases 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Endometrioid 1 Breast Carcinoma In Situ 1 Breast Cancer Survivors 1 Brain Neoplasms 1 Bone Neoplasms 1 Atypical Squamous Cells of the Cervix 1

Interventions

Doxorubicin 15 pembrolizumab 12 Cyclophosphamide 9 Surgical Procedures, Operative 8 Gemcitabine 8 Blood Specimen Collection 8 Ifosfamide 7 Surveys and Questionnaires 6 Nivolumab 6 Trabectedin 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Drug Therapy 5 fludarabine 4 Temozolomide 4 Specimen Handling 4 Radiation Dose Hypofractionation 4 Biopsy 4 selinexor 3 pazopanib 3 liposomal doxorubicin 3 cabozantinib 3 atezolizumab 3 anlotinib 3 Radiation 3 Observation 3 Docetaxel 3 Dacarbazine 3 trastuzumab deruxtecan 2 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma × Restraint, Physical × Clear all

NCT05051059 2026-03-16

QOLSarcoma

Universitaire Ziekenhuizen KU Leuven

Phase NA Recruiting

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡